Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
141.34
-0.21 (-0.15%)
Sep 18, 2026, 2:08 PM EDT - Market open
Insulet Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 3,053 | 2,901 | 2,708 | 2,522 | 2,360 | 2,199 | 2,072 | 1,984 | 1,873 | 1,781 | 1,697 | 1,557 | 1,465 | 1,368 | 1,305 | 1,243 | 1,178 | 1,142 | 1,099 | 1,037 |
Revenue Growth | 29.41% | 31.92% | 30.73% | 27.12% | 26.00% | 23.48% | 22.07% | 27.42% | 27.82% | 30.17% | 30.02% | 25.23% | 24.36% | 19.80% | 18.79% | 19.87% | 18.33% | 19.11% | 21.50% | 19.53% |
Gross Profit Gross Profit Growth | 2,170 | 2,060 | 1,940 | 1,789 | 1,656 | 1,548 | 1,446 | 1,389 | 1,294 | 1,215 | 1,160 | 1,026 | 968.9 | 894.3 | 805.6 | 838.3 | 801.9 | 794.3 | 752.1 | 700 |
Operating Income Operating Income Growth | 515.6 | 507.1 | 473.8 | 423.5 | 393.9 | 340.8 | 308.9 | 318.6 | 274.6 | 237.7 | 220.1 | 120.2 | 115.8 | 85.3 | 57.6 | 127.9 | 121.9 | 147.6 | 126 | 69 |
Net Income Net Income Growth | 375.3 | 302.8 | 247.1 | 246.2 | 236.1 | 402.2 | 418.3 | 420.9 | 395.3 | 234 | 206.3 | 120 | 62.9 | 0.6 | 4.6 | 16.8 | 34.6 | 44.6 | 16.8 | -29.5 |
Earnings Per Share EPS Growth | 5.30 | 4.29 | 3.48 | 3.46 | 3.32 | 5.55 | 5.78 | 5.74 | 5.44 | 3.31 | 2.94 | 1.71 | 0.90 | 0.01 | 0.07 | 0.23 | 0.50 | 0.64 | 0.24 | -0.44 |
EPS Growth | 59.41% | -22.69% | -39.85% | -39.75% | -38.92% | 67.46% | 96.55% | 235.68% | 507.10% | 38259.20% | 4338.47% | 645.54% | 80.52% | -98.65% | -72.37% | - | - | 402.74% | 140.00% | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
US Omnipod US Omnipod Growth | 2,125 | 2,034 | 1,920 | 1,796 | 1,694 | 1,593 | 1,509 | 1,460 | 1,385 | 1,310 | 1,251 | 1,133 | 1,050 | 969.7 | 884.8 | 799.1 | 728.2 | 682.3 | 651.5 | 610.2 |
International Omnipod International Omnipod Growth | 910.8 | 844.8 | 754.2 | 682.2 | 618 | 560.4 | 523.4 | 487.8 | 451.3 | 426.8 | 410.1 | 393.9 | 380.5 | 366.2 | 363 | 358.1 | 363.2 | 365.4 | 359.9 | 356.5 |
Drug Delivery Drug Delivery Growth | 18.1 | 22.5 | 34.1 | 44 | 47.2 | 45.1 | 38.9 | 35.9 | 36.3 | 44.2 | 36 | 30.5 | 34.5 | 32.1 | 57.5 | 86.1 | 86.7 | 94.2 | 87.4 | 70.5 |
Revenue (Total) Revenue (Total) Growth | 3,054 | 2,901 | 2,708 | 2,522 | 2,360 | 2,199 | 2,072 | 1,984 | 1,873 | 1,781 | 1,697 | 1,557 | 1,465 | 1,368 | 1,305 | 1,243 | 1,178 | 1,142 | 1,099 | 1,017 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 534.9 | 480.4 | 716.1 | 757.4 | 1,122 | 1,283 | 958.8 | 902.6 | 821 | 751.2 | 704.2 | 685.4 | 660.1 | 620.7 | 674.7 | 722 | 708.6 | 709.6 | 791.6 | 857.1 |
Total Debt Total Debt Growth | 948.4 | 1,014 | 1,003 | 1,076 | 1,455 | 1,749 | 1,434 | 1,441 | 1,433 | 1,438 | 1,449 | 1,454 | 1,434 | 1,429 | 1,433 | 1,407 | 1,412 | 1,416 | 1,287 | 1,286 |
Net Cash (Debt) Net Cash Growth | -413.5 | -533.6 | -286.6 | -318.2 | -333.8 | -465.5 | -475.4 | -538.6 | -612.1 | -686.6 | -744.6 | -768.5 | -774.2 | -808.4 | -758.1 | -684.7 | -702.9 | -706.6 | -494.9 | -428.8 |
Net Cash Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.79 | -7.53 | -3.99 | -4.40 | -4.62 | -6.29 | -6.43 | -7.05 | -8.11 | -9.21 | -10.11 | -10.90 | -11.01 | -11.55 | -10.84 | -9.76 | -10.04 | -10.16 | -7.22 | -6.41 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 511.2 | 619.3 | 569.3 | 533.5 | 516.1 | 406.4 | 430.2 | 327.9 | 275.6 | 232.8 | 145.7 | 151.2 | 151.9 | 133.2 | 119 | 42.8 | -39.7 | -46.7 | -68.1 | -25.6 |
Capital Expenditures CapEx Growth | -217.5 | -203.6 | -191.6 | -110.1 | -111.2 | -115.1 | -124.9 | -100.6 | -94 | -87.2 | -75.6 | -110.7 | -121.7 | -120.6 | -122.9 | -90.3 | -86.5 | -91.8 | -111.9 | -130.9 |
Free Cash Flow Free Cash Flow Growth | 293.7 | 415.7 | 377.7 | 423.4 | 404.9 | 291.3 | 305.3 | 227.3 | 181.6 | 145.6 | 70.1 | 40.5 | 30.2 | 12.6 | -3.9 | -47.5 | -126.2 | -138.5 | -180 | -156.5 |
Free Cash Flow Growth | -27.46% | 42.70% | 23.71% | 86.27% | 122.96% | 100.07% | 335.52% | 461.24% | 501.33% | 1055.56% | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Gross Margin | 71.08% | 71.01% | 71.63% | 70.93% | 70.18% | 70.40% | 69.79% | 70.00% | 69.11% | 68.22% | 68.35% | 65.92% | 66.13% | 65.37% | 61.72% | 67.42% | 68.07% | 69.56% | 68.45% | 67.49% |
Operating Margin | 16.89% | 17.48% | 17.50% | 16.79% | 16.69% | 15.50% | 14.91% | 16.06% | 14.66% | 13.35% | 12.97% | 7.72% | 7.90% | 6.24% | 4.41% | 10.29% | 10.35% | 12.93% | 11.47% | 6.65% |
Pretax Margin | 16.20% | 13.94% | 12.54% | 12.32% | 11.47% | 13.34% | 14.49% | 14.95% | 14.28% | 13.75% | 12.65% | 8.29% | 4.76% | 0.37% | 0.75% | 1.68% | 3.55% | 4.33% | 1.87% | -3.03% |
Profit Margin | 12.29% | 10.44% | 9.12% | 9.76% | 10.01% | 18.29% | 20.19% | 21.22% | 21.11% | 13.14% | 12.16% | 7.71% | 4.29% | 0.04% | 0.35% | 1.35% | 2.94% | 3.91% | 1.53% | -2.84% |
FCF Margin | 9.62% | 14.33% | 13.95% | 16.79% | 17.16% | 13.25% | 14.74% | 11.46% | 9.70% | 8.18% | 4.13% | 2.60% | 2.06% | 0.92% | -0.30% | -3.82% | -10.71% | -12.13% | -16.38% | -15.09% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | 28.10 | 48.78 | 80.92 | 88.27 | 93.65 | 45.85 | 43.78 | 38.77 | 35.76 | 51.22 | 73.44 | 92.80 | 319.49 | 36968.66 | 4444.57 | 947.69 | 436.76 | 413.43 | 1092.27 | - |
Forward PE | 22.76 | 33.07 | 49.26 | 61.76 | 70.53 | 62.73 | 70.67 | 70.56 | 64.49 | 56.47 | 93.67 | 83.53 | 178.16 | 240.35 | 227.87 | 257.58 | 176.17 | 210.79 | 227.00 | 230.39 |
P/FCF Ratio | 35.91 | 35.53 | 52.94 | 51.33 | 54.61 | 63.31 | 59.98 | 71.80 | 77.83 | 82.32 | 216.14 | 274.96 | 665.43 | 1760.41 | - | - | - | - | - | - |
PS Ratio | 3.45 | 5.09 | 7.38 | 8.62 | 9.37 | 8.39 | 8.84 | 8.23 | 7.55 | 6.73 | 8.93 | 7.15 | 13.72 | 16.21 | 15.66 | 12.81 | 12.83 | 16.15 | 16.70 | 18.87 |